NYU Abu Dhabi researchers develop the first-ever ingestible electroceutical device to control appetite by hormone modulation
Abu Dhabi, UAE – A team of researchers at NYU Abu Dhabi (NYUAD), led by Professor Khalil Ramadi, Director of the Laboratory for Advanced Neuroengineering and Translational Medicine, have developed a first-of-its-kind ingestible electroceutical device for the neuromodulation of the gut-brain axis, the signaling pathway between the gastrointestinal tract and central nervous system. The ingestible capsule is a non-invasive and precise method that could be used to modulate hunger levels and treat metabolic and neurologic diseases. This was developed in collaboration with Professor Giovanni Traverso of MIT, who is a joint senior author of the study and James McRae, a graduate student at MIT, who is first co-author of the paper published in the journal Science Robotics.
The FLASH system ut